The heart rhythm and cardiac stimulation unit of the Grenoble Alpes University Hospital (CHUGA for short) is one of the world’s first healthcare institutions to use a new communicating implantable cardiac monitor (ICM). This small device (4.9 cm long, 0.94 cm wide and 3.1 mm thick), installed under local anesthetic, continuously records cardiac events and transmits the data to a dedicated secure site via a smartphone app. More than twenty patients have been using the device since May to discreetly and effectively monitor their heart rates. CHUGA nurses also check the data and report any problems to the cardiologists.
The new ICM can help to detect atrial fibrillation and arrhythmias, and also explain symptoms such as syncopations and shortness of breath which may be caused by cardiac dysfunction.